SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950116-00-002614
Filing Date
2000-10-30
Accepted
2000-10-30 00:00:00
Documents
5
Period of Report
2000-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K 0001.txt 10-K 256205
2 EXHIBIT 4.3.2 0002.txt EX-4.3.2 27971
3 SUBSIDIARIES OF THE REGISTRANT 0003.txt EX-21 695
4 EXHIBIT 23.1 0004.txt EX-23.1 874
5 FINANCIAL DATA SCHEDULE 0005.txt EX-27 1987
  Complete submission text file 0000950116-00-002614.txt   289750
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO M5J A1
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-25169 | Film No.: 749011
SIC: 2834 Pharmaceutical Preparations